Table of Contents
For decades, coal tar shampoos have been a trusted and affordable treatment for chronic skin conditions like psoriasis and eczema. Yet, to the dismay of many, these products are vanishing from store shelves, leaving patients searching for alternatives. What’s behind the mysterious disappearance of these once-common remedies?
Coal tar, a thick, brown byproduct of coal-processing, has long been valued for its ability to reduce inflammation, itchiness, and the overproduction of skin cells. Products like Polytar shampoo and Carbo Dome cream have gained a loyal following among individuals like Ray Jobling, a retired academic who has used coal tar-based treatments for decades to manage his psoriasis.
But in recent years, these products have become increasingly hard to find. What once cost just over £2 for a 250ml bottle of Polytar now comes with a hefty price tag of over £21 on international marketplaces like Amazon. With supply dwindling, consumers are paying inflated rates to purchase coal tar shampoos from overseas—mainly from Thailand.
The shortage of coal tar products has sparked frustration and confusion among patients and healthcare professionals alike. While there are conflicting reasons cited by manufacturers, several theories have emerged:
The European Union implemented stricter regulations last year, banning coal tar in cosmetics due to concerns it might be carcinogenic. Although coal tar shampoos and creams are classified as medical products, this regulatory shift seems to have impacted their availability.
Manufacturers like GlaxoSmithKline have attributed the absence of Polytar to changes in licensing and production, with a projected restock only by 2016. Similarly, Sandoz, the maker of Carbo Dome, mentioned supply chain disruptions from their coal tar supplier as a key issue.
There’s speculation that coal tar products are being deprioritized because they’re less profitable than newer treatments. For example, Dovobet, a cream containing steroids and vitamin D, costs the NHS over £61 for a 120g tube, far more than the cost of coal tar products.
For individuals living with psoriasis—around 2% of the population—access to effective treatments is vital. Psoriasis can cause severe discomfort, cracked skin, and even hospitalization in extreme cases. Many, like Ray Jobling, fear that the absence of coal tar shampoos will push patients toward stronger alternatives, such as prescription steroid creams, which can have significant side effects, including skin thinning.
The emotional toll is equally significant. Chronic conditions like psoriasis often affect confidence and quality of life. Losing a treatment that has worked for years can feel overwhelming, particularly when the reasons for its removal are unclear.
Dr. Julia Schofield, a consultant dermatologist, emphasizes that the lack of communication from pharmaceutical companies has been problematic for both patients and doctors. "Often, the first time we hear about supply issues is when patients inform us they can’t get a product we prescribed," says Dr. Schofield.
Meanwhile, patient organizations like the Psoriasis Association and the National Eczema Society are inundated with queries and concerns from affected individuals. Carla Renton, from the Psoriasis Association, highlights the emotional impact of the shortage, calling it "traumatic for those who rely on these treatments."
Despite the challenges, it’s important to stay informed about alternatives and remain proactive in managing chronic skin conditions. While coal tar products may be harder to find, there are other treatments and approaches available. Here are a few tips for navigating the situation:
Your doctor can recommend alternative therapies, including steroid creams, vitamin D treatments, or light therapy.
If you choose to purchase coal tar shampoos or creams online, ensure you’re buying from reputable sellers to avoid counterfeit products.
Patient organizations and forums can provide resources, advice, and emotional support for individuals dealing with psoriasis and eczema.
Reach out to manufacturers or regulatory bodies to request clearer communication about product availability.
The disappearance of coal tar products highlights larger issues in the pharmaceutical industry, particularly around communication, profitability, and patient access to affordable treatments. Manufacturers and regulators must prioritize transparency to avoid leaving patients in the dark.
While newer treatments may represent scientific advancement, they come at a cost—both financially and in terms of patient trust. The case of coal tar shampoos serves as a reminder of the need to balance innovation with accessibility, ensuring that effective treatments remain available to those who depend on them.
